We are live on ! Find out more
AQST icon

Aquestive Therapeutics
AQST

46 hedge funds and large institutions have $64.4M invested in Aquestive Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more call options, than puts

Call options by funds: $1.07M | Put options by funds: $810K

4% more capital invested

Capital invested by funds: $62M → $64.4M (+$2.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4.7% less ownership

Funds ownership: 42.7% → 38% (-4.7%)

23% less funds holding

Funds holding: 60 → 46 (-14)

33% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 18

74% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 19

Holders
46
Holders Change
-14
Holders Change %
-23.33%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
12
Reduced
18
Closed
19
Calls
$1.07M
Puts
$810K
Net Calls
+$262K
Net Calls Change
+$98K

Top Buyers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
+$782K
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$580K
3
BCM
Bridgeway Capital Management
Texas
+$220K
4
Citadel Advisors
Citadel Advisors
Florida
+$164K
5
JF
Jump Financial
Illinois
+$74.8K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$1.21M
2
CCM
CAAS Capital Management
New York
-$862K
3
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$596K
4
Millennium Management
Millennium Management
New York
-$447K
5
E
Ergoteles
New York
-$361K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$182K +$164K +41,711 New
Barclays
27
Barclays
United Kingdom
$122K -$13.6K -3,456 -11%
CAM
28
Cresset Asset Management
Illinois
$109K – – –
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$96K +$2.74K +700 +3%
Wells Fargo
30
Wells Fargo
California
$93K +$78 +20 +0.1%
FAIM
31
Financial Advocates Investment Management
Washington
$74K – – –
Group One Trading
32
Group One Trading
Illinois
$69K +$7.21K +1,839 +13%
UBS Group
33
UBS Group
Switzerland
$44K -$15.9K -4,060 -29%
Bank of America
34
Bank of America
North Carolina
$33K -$83K -21,171 -74%
Rockefeller Capital Management
35
Rockefeller Capital Management
New York
$13K – – –
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$11K -$18.3K -4,674 -64%
MIFH
37
Migdal Insurance & Financial Holdings
Israel
$10K +$9.43K +2,406 New
Osaic Holdings
38
Osaic Holdings
Arizona
$9K – – –
First Manhattan
39
First Manhattan
New York
$8K -$2.35K -600 -23%
QT
40
Quantbot Technologies
New York
$6K +$5.49K +1,400 New
CG
41
Cutler Group
California
$1K -$392 -100 -25%
NFG
42
Next Financial Group
Texas
$1K – – –
HI
43
Harbour Investments
Wisconsin
$1K +$588 +150 +200%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$510 -$408 -104 -47%
CCM
45
CAAS Capital Management
New York
– -$862K -217,091 Closed
AIMCA
46
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$596K -150,000 Closed
E
47
Ergoteles
New York
– -$361K -90,900 Closed
TEE
48
Tibra Equities Europe
United Kingdom
– -$310K -78,100 Closed
Charles Schwab
49
Charles Schwab
California
– -$297K -74,757 Closed
HF
50
HRT Financial
New York
– -$198K -49,907 Closed
1
2
3

AQST Hedge Fund Activity: Q3 2021 in Review

46 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Aquestive Therapeutics (AQST) for Q3 2021, worth a combined $64.4M — up 3.9% from $62M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of AQST and 5 opened new positions — a net loss of 14 holders — while 18 trimmed existing stakes and 12 added.

The largest buyer was GSA Capital Partners, adding an estimated $782K. The largest seller was Morgan Stanley, cutting an estimated $1.21M.

  • 46 institutional investors held Aquestive Therapeutics (AQST) as of Q3 2021, down from 60 in Q2 2021.
  • Funds reported $64.4M of Aquestive Therapeutics stock for Q3 2021, up 3.9% quarter-over-quarter.
  • 5 funds opened new Aquestive Therapeutics positions in Q3 2021 and 19 closed out, a net change of -14 holders.
  • The largest Aquestive Therapeutics buyer in Q3 2021 was GSA Capital Partners, an estimated $782K added.
  • The largest Aquestive Therapeutics seller in Q3 2021 was Morgan Stanley, an estimated $1.21M sold.

Based on aggregated 13F filings for Q3 2021.